Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Advanced Medical Solutions Group plc    AMS   GB0004536594

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201420152016201720182019
Sales63,068,682,694,3102110
EBITDA17,919,922,128,330,032,6
Operating profit (EBIT)15,617,419,525,026,729,0
Pre-Tax Profit (EBT)15,217,019,124,326,028,2
Net income12,914,115,719,220,622,3
P/E ratio20,627,130,035,833,431,0
EPS (GBp )6,086,687,389,039,6710,4
Dividend per Share (GBp )0,700,800,921,071,191,30
Yield0,56%0,44%0,41%0,33%0,37%0,40%
Reference price (GBp )125.25181.25221.75323323323
Announcement Date03/04/2015
07:21am
03/16/2016
07:00am
03/14/2017
07:52am
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201420152016201720182019
Debt------
Finance17,334,251,166,585,999,5
Operating income (EBITDA)17,919,922,128,330,032,6
Leverage
(Debt/EBITDA)
------
Capital Expenditure1,481,911,522,552,401,50
Book Value Per Share (BVPS)44,8 PNC49,6 PNC59,1 PNC69,2 PNC79,0 PNC84,0 PNC
Cash Flow per Share7,83 PNC10,1 PNC9,33 PNC5,90 PNC9,80 PNC9,60 PNC
Announcement Date03/04/2015
07:21am
03/16/2016
07:00am
03/14/2017
07:52am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 687 M GBP -
Entreprise Value (EV) 620 M GBP 601 M GBP
Valuation 2017e 2018e
P/E ratio (Price / EPS) 35,8x 33,4x
Capitalization / Revenue 7,28x 6,71x
EV / Revenue 6,58x 5,87x
EV / EBITDA 21,9x 20,0x
Yield (DPS / Price) 0,33% 0,37%
Price to book (Price / BVPS) 4,67x 4,09x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 26,5% 26,1%
operating Leverage (Delta EBIT / Delta Sales) 2,01x 0,80x
Net Margin (Net Profit / Revenue) 20,3% 20,1%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 13,5% 12,7%
Rate of Dividend 11,9% 12,3%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   2,71% 2,35%
Cash Flow / Sales 13,3% 20,4%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) -2,35x -2,86x
EPS & Dividend